布普伦诺芬诱导的阿片类药物戒断综合征通过辅助来缓解:一项临床试验
Mohammad Moshiri1, Bita Chaeideh2, Mohsen Ebrahimi3
1Medical Toxicology Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran; Department of Clinical Toxicology and Poisoning, Imam Reza (p) Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Journal of substance use and addiction treatment
|February 3, 2024
概括
硫酸显著降低了急性阿片类药物戒断综合征 (OWS) 的严重程度. 这种NMDA受体抗剂为OWS管理提供了一个有前途的治疗选择,需要进一步研究.
科学领域:
- 药理学 药理学是指药理学的学科.
- 毒理学 毒理学 毒理学
- 紧急医疗 紧急医疗
背景情况:
- 冲击性阿片类药物戒断综合征 (OWS) 是一种严重的疾病,通常由制药剂引发.
- 在长期使用阿片类药物的人群中,N-甲基-d-酸盐 (NMDA) 受体的重新激活可能导致强烈的OWS.
- 了解OWS的机制对于开发有效治疗方法至关重要.
研究的目的:
- 评价硫酸 (MGSO4) 作为NMDA受体对抗剂在缓解沉性OWS时的疗效.
- 为了比较硫酸盐与常规疗法相结合的效果与单独的常规疗法.
主要方法:
- 进行了一项双盲随机临床试验,40名患者因使用布普伦诺芬而经历了急性OWS.
- 患者被分为两组:接受常规疗法的对照组和接受硫酸加常规疗法的干预组.
- 临床阿片类戒断量表 (COWS) 用于在基线,30分钟和治疗后2小时评估OWS严重程度.
主要成果:
- 与对照组相比,接受硫酸的干预组在30分钟 (11.20 ± 2.86) 和2小时 (3.2 ± 1.61) 后显示出明显较低的COWS分数 (分别为14.65 ± 2.36和11.25 ± 3.27).
- 干预组的患者需要显著降低辅助克洛尼丁和泽帕姆的剂量.
- 在硫酸组,血清含量从1.71 ± 0.13 mmol/L增加到2.73 ± 0.13 mmol/L.
结论:
- 硫酸显示出显著的能力,以减少沉性阿片类药物戒断综合征的严重性.
- 这些发现表明,硫酸是OWS治疗方案的潜在有价值的补充.
- 需要进一步的研究来证实这些有希望的结果,并探索最佳的剂量策略.
相关概念视频
01:15Opioid Analgesics: Synthetic and Semisynthetic Opioids
300
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
300
01:25Analgesia and Pain Management
623
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
623
01:17Drugs for Treatment of Diarrhea-Predominant IBS
175
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
175
01:21Drugs for Treatment of Constipation-Predominant IBS
169
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
169
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
176
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
176
01:14CNS Depressants: Barbiturates and Benzodiazepines
267
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
267